Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
3 Years to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Growth failure due to growth hormone insufficiency (GHD)
Turner syndrome: established diagnosis according to sex chromosome analysis, or
Growth retardation in children with chronic renal disorders
Breast feeding women
Suspected or know allergy to trial product
Participating in any other trial involving other investigational products within the last 3 months
Previous participation in the trial
Other daily injection therapy (non-growth hormone, e.g insulin-therapy)
Endocrine System Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Central Nervous System Diseases
Nervous System Diseases
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs